• Awards and Achievements
  • Student, Alumnus and Professor Stories
Professor Alfonso H.W. Ngan, Kingboard Endowed Professor in Materials Engineering, and Chair Professor in Material Sciences and Engineering of the Department of Mechanical Engineering at the University of Hong Kong (HKU), has been elected as an International Fellow of the Royal Academy of Engineering (FREng) in the U.K. He is the only international fellow from Asia named by the Academy this year.
  • Awards and Achievements
  • Student, Alumnus and Professor Stories
Dr Koon Yee Wan of the Faculty of Arts, and Professor Daniel Wong Fu Keung of the Faculty of Social Sciences at the University of Hong Kong (HKU) have received awards under the 2021 UGC Teaching Award scheme. 
  • Research
  • Student, Alumnus and Professor Stories
In a journal article published in Biomaterials Science titled “Biofilm inhibition in oral pathogens by nanodiamonds”, scientists from the Faculty of Engineering and the Faculty of Dentistry of the University of Hong Kong (HKU) revealed for the first time the inhibitory effect on oral pathogenic biofilms by high-pressure high-temperature (HPHT) NDs.
  • Research
  • Student, Alumnus and Professor Stories
The Laboratory for Space Research (LSR) and Department of Physics of The University of Hong Kong(HKU) joined hands with collaborators from the UK, Spain, Hungary and France, pursued an investigation to unravel this mystery via newly uncovered clues of their own discovery. Remarkably, the guest star of AD 1181, reported at the time to be as bright as the planet Saturn, was the only historical supernova(SN) of the last thousand years that has been without identification with a real object.
  • Awards and Achievements
  • Research
  • Student, Alumnus and Professor Stories
Professor Yao Wang from the Faculty of Science and Professor Mingxin Huang from the Faculty of Engineering of the University of Hong Kong (HKU), have both been awarded the 2021 Xplorer Prize. Supported by Tencent, the award is presented to young scientists under the age of 45 who demonstrate exceptional quality and innovation in their field of research.
  • Awards and Achievements
  • Research
  • Student, Alumnus and Professor Stories
A multi-institutional research team led by scientists at the AIDS Institute and Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) has identified BilA-SG, a tandem bi-specific broadly neutralising antibody, as a promising universal drug for human immunodeficiency virus-1 (HIV-1) prevention and functional cure. A single pre-exposure intramuscular injection of BilA-SG was found to be 100% effective in preventing a pathogenic virus and a similar post-exposure treatment sustained 100% survival and complete virus suppression in most of the non-human primate models for two years. The new findings are now published in the August issue of Cell Reports, one of the world’s leading scientific journals.
  • Awards and Achievements
  • Research
  • Student, Alumnus and Professor Stories
Professor Yuguo Li, Chair Professor of Building Environment at the University of Hong Kong’s Department of Mechanical Engineering, has been honored the Louise and Bill Holladay Distinguished Fellow Award 2021 by The American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE), in recognition of his contributions and pre-eminence in engineering and research work.
  • Awards and Achievements
  • Research
  • Student, Alumnus and Professor Stories
Young researchers at the University of Hong Kong have achieved outstanding results in the Excellent Young Scientists Fund (Hong Kong and Macau) for 2021.
  • Awards and Achievements
  • Research
Researchers at the LKS Faculty of Medicine of The University of Hong Kong (HKUMed) have uncovered the important roles of tumour-associated macrophages and identified an important TIGIT-NECTIN2 immune checkpoint axis (interacting partners) in liver cancer, which helps to create an immunosuppressive microenvironment in promoting the growth of liver cancer, meanwhile indicating the possibility to restore the immune attack on tumour cells by inactivating the immune checkpoint. The novel and translational findings provide useful pre-clinical foundation and mechanistic insight for developing onco-immunotherapeutics in precision liver cancer treatment. The findings are now published in Nature Communications, a peer-reviewed multidisciplinary scientific journal.
The collaborative research team formed by the Department of Pharmacology and Pharmacy and Department of Microbiology, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has developed an inhalable dry powder formulation of tamibarotene, a repurposed drug that exhibits broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV and influenza A H1N1 virus following pulmonary delivery. The work has been published online in Advanced Therapeutics in June 2021. A provisional application has been filed to the United States Patent and Trademark Office based on this work.